Tazarotene-induced gene 1 inhibits prostaglandin E2-stimulated HCT116 colon cancer cell growth

Journal of Biomedical Science

Volumn 18, Issue 1, 2011, Pages

  Tsai, Fu Ming ^a   Wu, Chang Chieh ^b   Shyu, Rong Yaun ^a,c   Wang, Chun Hua ^a   Jiang, Shun Yuan ^a  

^a BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^c TZU CHI UNIVERSITY   (Taiwan)

Author keywords

catenin; colon cancer; GRK5; prostaglandin E2; RARRES1; TIG1

Indexed keywords

ANTINEOPLASTIC AGENT; BETA CATENIN; CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; G PROTEIN COUPLED RECEPTOR KINASE 5; LUCIFERASE; MIFEPRISTONE; PROSTAGLANDIN E2; T CELL FACTOR PROTEIN; TAZAROTENE INDUCED PROTEIN 1A; TAZAROTENE INDUCED PROTEIN 1B; UNCLASSIFIED DRUG; GRK5 PROTEIN, HUMAN; MEMBRANE PROTEIN; RARRES1 PROTEIN, HUMAN; WNT PROTEIN;

ARTICLE; CANCER INHIBITION; CELL GROWTH; CELL PROLIFERATION; CELL STRAIN HCT116; COLON CANCER; CONFOCAL MICROSCOPY; ENZYME ASSAY; ENZYME IMMUNOASSAY; GENE EXPRESSION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING; COLON TUMOR; DRUG ANTAGONISM; GENETICS; METABOLISM; PATHOLOGY;

BETA CATENIN; CELL PROLIFERATION; COLONIC NEOPLASMS; CYCLIC AMP; DINOPROSTONE; G-PROTEIN-COUPLED RECEPTOR KINASE 5; HCT116 CELLS; HUMANS; MEMBRANE PROTEINS; SIGNAL TRANSDUCTION; UP-REGULATION; WNT PROTEINS;

EID: 82255195374     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-18-88     Document Type: Article

References (40)

1. Tazarotene-induced gene 1 (TIG1), a novel retinoic acid receptor-responsive gene in skin. Nagpal S, Patel S, Asano AT, Johnson AT, Duvic M, Chandraratna RA, J Invest Dermatol 1996 106 269 274 (Pubitemid 26096423)
2. Tazarotene-induced gene 1 (TIG1) expression in prostate carcinomas and its relationship to tumorigenicity. Jing C, El-Ghany MA, Beesley C, Foster CS, Rudland PS, Smith P, Ke Y, J Natl Cancer Inst 2002 94 482 490 (Pubitemid 34411286)
3. Discovery of epigenetically masked tumor suppressor genes in endometrial cancer. Takai N, Kawamata N, Walsh CS, Gery S, Desmond JC, Whittaker S, Said JW, Popoviciu LM, Jones PA, Miyakawa I, Koeffler HP, Mol Cancer Res 2005 3 261 269 (Pubitemid 40656813)
4. Methylation profiles of multiple CpG island loci in extrahepatic cholangiocarcinoma versus those of intrahepatic cholangiocarcinomas. Kim BH, Cho NY, Choi M, Lee S, Jang JJ, Kang GH, Arch Pathol Lab Med 2007 131 923 930 (Pubitemid 46906384)
5. Role of the RARRES1 gene in nasopharyngeal carcinoma. Kwok WK, Pang JC, Lo KW, Ng HK, Cancer Genet Cytogenet 2009 194 58 64
6. Silencing of the retinoid response gene TIG1 by promoter hypermethylation in nasopharyngeal carcinoma. Kwong J, Lo KW, Chow LS, Chan FL, To KF, Huang DP, Int J Cancer 2005 113 386 392 (Pubitemid 40038705)
7. DNA methylation of genes linked to retinoid signaling in squamous cell carcinoma of the esophagus: DNA methylation of CRBP1 and TIG1 is associated with tumor stage. Mizuiri H, Yoshida K, Toge T, Oue N, Aung PP, Noguchi T, Yasui W, Cancer Sci 2005 96 571 577 (Pubitemid 41488420)
8. DNA methylation of genes linked with retinoid signaling in gastric carcinoma: expression of the retinoid acid receptor beta, cellular retinol-binding protein 1, and tazarotene-induced gene 1 genes is associated with DNA methylation. Shutoh M, Oue N, Aung PP, Noguchi T, Kuraoka K, Nakayama H, Kawahara K, Yasui W, Cancer 2005 104 1609 1619 (Pubitemid 41437423)
9. Hypermethylation and silencing of the putative tumor suppressor Tazarotene-induced gene 1 in human cancers. Youssef EM, Chen XQ, Higuchi E, Kondo Y, Garcia-Manero G, Lotan R, Issa JP, Cancer Res 2004 64 2411 2417 (Pubitemid 38523894)
10. Methylation of the retinoid response gene TIG1 in prostate cancer correlates with methylation of the retinoic acid receptor beta gene. Zhang J, Liu L, Pfeifer GP, Oncogene 2004 23 2241 2249 (Pubitemid 38482540)
11. G protein-coupled receptor kinase 5 mediates Tazarotene-induced gene 1-induced growth suppression of human colon cancer cells. Wu CC, Tsai FM, Shyu RY, Tsai YM, Wang CH, Jiang SY, BMC Cancer 2011 11 175
12. Identification of differentially expressed genes in spontaneously regressing melanoma using the MeLiM swine model. Rambow F, Malek O, Geffrotin C, Leplat JJ, Bouet S, Piton G, Hugot K, Bevilacqua C, Horak V, Vincent-Naulleau S, Pigment Cell Melanoma Res 2008 21 147 161 (Pubitemid 351551222)
13. Involvement of tazarotene-induced gene 1 in proliferation and differentiation of human adipose tissue-derived mesenchymal stem cells. Ohnishi S, Okabe K, Obata H, Otani K, Ishikane S, Ogino H, Kitamura S, Nagaya N, Cell Prolif 2009 42 309 316
14. RARRES1 expression is significantly related to tumour differentiation and staging in colorectal adenocarcinoma. Wu CC, Shyu RY, Chou JM, Jao SW, Chao PC, Kang JC, Wu ST, Huang SL, Jiang SY, Eur J Cancer 2006 42 557 565
15. Tumor suppressor RARRES1 interacts with cytoplasmic carboxypeptidase AGBL2 to regulate the alpha-tubulin tyrosination cycle. Sahab ZJ, Hall MD, Me Sung Y, Dakshanamurthy S, Ji Y, Kumar D, Byers SW, Cancer Res 2011 71 1219 1228
16. The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment. Greenhough A, Smartt HJ, Moore AE, Roberts HR, Williams AC, Paraskeva C, Kaidi A, Carcinogenesis 2009 30 377 386
17. Prostaglandin E2 receptor distribution and function in the gastrointestinal tract. Dey I, Lejeune M, Chadee K, Br J Pharmacol 2006 149 611 623 (Pubitemid 44748054)
18. Cyclooxygenase-2-derived prostaglandin E2 activates beta-catenin in human cholangiocarcinoma cells: evidence for inhibition of these signaling pathways by omega 3 polyunsaturated fatty acids. Lim K, Han C, Xu L, Isse K, Demetris AJ, Wu T, Cancer Res 2008 68 553 560 (Pubitemid 351380084)
19. Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis. Castellone MD, Teramoto H, Williams BO, Druey KM, Gutkind JS, Science 2005 310 1504 1510 (Pubitemid 41746348)
20. FP prostanoid receptor activation of a T-cell factor/beta-catenin signaling pathway. Fujino H, Regan JW, J Biol Chem 2001 276 12489 12492
21. Nuclear stabilization of beta-catenin and inactivation of glycogen synthase kinase-3beta by gonadotropin-releasing hormone: targeting Wnt signaling in the pituitary gonadotrope. Gardner S, Maudsley S, Millar RP, Pawson AJ, Mol Endocrinol 2007 21 3028 3038 (Pubitemid 350223512)
22. Prostaglandin E2 Stimulates the beta-catenin/T cell factor-dependent transcription in colon cancer. Shao J, Jung C, Liu C, Sheng H, J Biol Chem 2005 280 26565 26572 (Pubitemid 41022254)
23. GPCR signalling in hypertension: role of GRKs. Harris DM, Cohn HI, Pesant S, Eckhart AD, Clin Sci (Lond) 2008 115 79 89
24. Imaging of muscarinic acetylcholine receptor signaling in hippocampal neurons: evidence for phosphorylation-dependent and -independent regulation by G-protein-coupled receptor kinases. Willets JM, Nash MS, Challiss RA, Nahorski SR, J Neurosci 2004 24 4157 4162 (Pubitemid 38620790)
25. Heptahelical receptor signaling: beyond the G protein paradigm. Hall RA, Premont RT, Lefkowitz RJ, J Cell Biol 1999 145 927 932 (Pubitemid 29270052)
26. Phosphorylation of p38 by GRK2 at the docking groove unveils a novel mechanism for inactivating p38MAPK. Peregrin S, Jurado-Pueyo M, Campos PM, Sanz-Moreno V, Ruiz-Gomez A, Crespo P, Mayor F Jr, Murga C, Curr Biol 2006 16 2042 2047 (Pubitemid 44604449)
27. The G-protein-coupled receptor kinase 5 inhibits NFkappaB transcriptional activity by inducing nuclear accumulation of IkappaB alpha. Sorriento D, Ciccarelli M, Santulli G, Campanile A, Altobelli GG, Cimini V, Galasso G, Astone D, Piscione F, Pastore L, Trimarco B, Iaccarino G, Proc Natl Acad Sci USA 2008 105 17818 17823
28. G-protein-coupled receptor kinase 5 phosphorylates p53 and inhibits DNA damage-induced apoptosis. Chen X, Zhu H, Yuan M, Fu J, Zhou Y, Ma L, J Biol Chem 2010 285 12823 12830
29. Highly sensitive cell-based assay system to monitor the sialyl Lewis × biosynthesis mediated by alpha1-3 fucosyltransferase-VII. Miyashiro M, Furuya S, Fujishige K, Sugita T, Biochem Biophys Res Commun 2004 324 98 107 (Pubitemid 39311465)
30. Ligand-dependent regulation of plasmid-based transgene expression in vivo. Abruzzese RV, Godin D, Burcin M, Mehta V, French M, Li Y, O'Malley BW, Nordstrom JL, Hum Gene Ther 1999 10 1499 1507 (Pubitemid 29318987)
31. Peroxisome-proliferator-activated receptor alpha agonists inhibit cyclo-oxygenase 2 and vascular endothelial growth factor transcriptional activation in human colorectal carcinoma cells via inhibition of activator protein-1. Grau R, Punzon C, Fresno M, Iniguez MA, Biochem J 2006 395 81 88
32. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, Kinzler KW, Science 1997 275 1787 1790 (Pubitemid 27136715)
33. Sulindac metabolites induce caspase- and proteasome-dependent degradation of beta-catenin protein in human colon cancer cells. Rice PL, Kelloff J, Sullivan H, Driggers LJ, Beard KS, Kuwada S, Piazza G, Ahnen DJ, Molecular cancer therapeutics 2003 2 885 892
34. Target disruption of the mutant beta-catenin gene in colon cancer cell line HCT116: preservation of its malignant phenotype. Sekine S, Shibata T, Sakamoto M, Hirohashi S, Oncogene 2002 21 5906 5911 (Pubitemid 35007241)
35. Prostaglandin receptor EP2 is responsible for cyclooxygenase-2 induction by prostaglandin E2 in mouse skin. Ansari KM, Sung YM, He G, Fischer SM, Carcinogenesis 2007 28 2063 2068 (Pubitemid 47543363)
36. Agonist-induced phosphorylation by G protein-coupled receptor kinases of the EP4 receptor carboxyl-terminal domain in an EP3/EP4 prostaglandin E(2) receptor hybrid. Neuschafer-Rube F, Oppermann M, Moller U, Boer U, Puschel GP, Mol Pharmacol 1999 56 419 428 (Pubitemid 29347620)
37. A polymorphism of G-protein coupled receptor kinase5 alters agonist-promoted desensitization of beta2-adrenergic receptors. Wang WC, Mihlbachler KA, Bleecker ER, Weiss ST, Liggett SB, Pharmacogenetics and genomics 2008 18 729 732
38. G Protein-coupled receptor kinases phosphorylate LRP6 in the Wnt pathway. Chen M, Philipp M, Wang J, Premont RT, Garrison TR, Caron MG, Lefkowitz RJ, Chen W, J Biol Chem 2009 284 35040 35048
39. Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. Sheng H, Shao J, Kirkland SC, Isakson P, Coffey RJ, Morrow J, Beauchamp RD, DuBois RN, The Journal of clinical investigation 1997 99 2254 2259 (Pubitemid 27203783)
40. Overexpression of cyclooxygenase-2 correlates with advanced stages of colorectal cancer. Zhang H, Sun XF, Am J Gastroenterol 2002 97 1037 1041 (Pubitemid 34408266)